SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VD's Model Portfolio & Discussion Thread

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cytokine1 who wrote (3744)12/16/1997 12:40:00 PM
From: Andreas Helke  Read Replies (2) of 9719
 
It is my experience that selling the biggest loosers is a pretty shure reciepe for disappointing portfolio performance. Once you are annoyed enough about the performance of your stocks to consider selling them at a considerable loss they are often cheap enough to seriously outperform the market after you sold them. Compaq is up 250% since I sold it at a loss in 1996 and Quantum is up 200% since I sold it at its 1996 bottom and at the 1997 peak it was up 500%.

With GENZL I am currently considering averageing down another time. I originally bought GENZL for $12 1/4 and averaged down at $10 and $8 1/8. Now I only wonder if I should wait until a bottom is in place or if I should consider todays prices as cheap enough to buy even if it still can get cheaper.

MDYN at $15 1/8 was the latest addition to my biotech portfolio.

Andreas
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext